Vaskulärer endothelialer Wachstumsfaktor C

Lee J et al. (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.

Machnik A et al. (2009) Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism.

Gordon K et al. (2013) Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.

Villefranc JA et al. (2013) A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development.

Hung CJ et al. (2003) Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors.

Karkkainen MJ et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.

Titze J et al. (2010) Sodium sensing in the interstitium and relationship to hypertension.

Slagman MC et al. (2012) Vascular endothelial growth factor C levels are modulated by dietary salt intake in proteinuric chronic kidney disease patients and in healthy subjects.

Liu F et al. (2011) Involvement of the lymphatic system in salt-sensitive hypertension in humans.

Wiig H et al. (2013) Immune cells control skin lymphatic electrolyte homeostasis and blood pressure.

Joukov V et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Orphanet article

NCBI article

OMIM.ORG article

Wikipedia Artikel